Concealed medicines for people with schizophrenia: a U.S. perspective.
Publication
, Journal Article
Stroup, S; Swartz, M; Appelbaum, P
Published in: Schizophr Bull
2002
Duke Scholars
Published In
Schizophr Bull
DOI
ISSN
0586-7614
Publication Date
2002
Volume
28
Issue
3
Start / End Page
537 / 542
Location
United States
Related Subject Headings
- United States
- Schizophrenia
- Psychiatry
- Psychiatry
- Physician's Role
- Personal Autonomy
- Patient Compliance
- Patient Advocacy
- Knowledge
- Informed Consent
Citation
APA
Chicago
ICMJE
MLA
NLM
Stroup, S., Swartz, M., & Appelbaum, P. (2002). Concealed medicines for people with schizophrenia: a U.S. perspective. Schizophr Bull, 28(3), 537–542. https://doi.org/10.1093/oxfordjournals.schbul.a006961
Stroup, Scott, Marvin Swartz, and Paul Appelbaum. “Concealed medicines for people with schizophrenia: a U.S. perspective.” Schizophr Bull 28, no. 3 (2002): 537–42. https://doi.org/10.1093/oxfordjournals.schbul.a006961.
Stroup S, Swartz M, Appelbaum P. Concealed medicines for people with schizophrenia: a U.S. perspective. Schizophr Bull. 2002;28(3):537–42.
Stroup, Scott, et al. “Concealed medicines for people with schizophrenia: a U.S. perspective.” Schizophr Bull, vol. 28, no. 3, 2002, pp. 537–42. Pubmed, doi:10.1093/oxfordjournals.schbul.a006961.
Stroup S, Swartz M, Appelbaum P. Concealed medicines for people with schizophrenia: a U.S. perspective. Schizophr Bull. 2002;28(3):537–542.
Published In
Schizophr Bull
DOI
ISSN
0586-7614
Publication Date
2002
Volume
28
Issue
3
Start / End Page
537 / 542
Location
United States
Related Subject Headings
- United States
- Schizophrenia
- Psychiatry
- Psychiatry
- Physician's Role
- Personal Autonomy
- Patient Compliance
- Patient Advocacy
- Knowledge
- Informed Consent